Needham Reiterates Buy on DocGo, Maintains $14 Price Target
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Ryan MacDonald has reiterated a 'Buy' rating on DocGo (NASDAQ:DCGO) and maintained a price target of $14.
September 18, 2023 | 9:34 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Ryan MacDonald has reiterated a 'Buy' rating on DocGo, maintaining a price target of $14. This could potentially boost investor confidence in the stock.
The reiteration of a 'Buy' rating by a Needham analyst, along with the maintenance of a $14 price target, indicates a positive outlook for DocGo. This could potentially lead to an increase in investor confidence and a short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100